643 results
Page 2 of 33
8-K
EX-1.1
25r607ivf1rc
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm
424B4
kg6aokyhn7dawnrm kj3
20 Apr 23
Prospectus supplement with pricing info
6:03pm
8-K
xl7 8vcungcloaa00q
6 Apr 23
Results of Operations and Financial Condition
7:58pm
8-K
EX-99.1
p0b7 dcjz
3 Apr 23
Windtree Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Key Business Updates
7:25am
8-K
EX-99.1
vzqkf pbqn4rozduksb
5 Dec 22
Other Events
7:48am
8-K
EX-99.1
48132eibr ipb9op
14 Nov 22
Windtree Therapeutics Reports Third Quarter 2022 Financial Results and Provides Key Business Updates
7:33am
8-K
EX-99.1
fzmtfeckc n85nar5z4n
23 Aug 22
Windtree Therapeutics Announces KL4 Surfactant and AEROSURF® Global License Agreement
8:30am
8-K
EX-99.1
adbs42n9t m5kwt9dt
11 Aug 22
Windtree Therapeutics Reports Second Quarter 2022 Financial Results and Provides Key Business Updates
4:06pm
8-K
EX-99.1
sy39yoyv iln2sqef
23 May 22
The study met its primary endpoint of improved systolic blood pressure (SBP) profile at 6 hours
4:01pm
8-K
EX-99.1
9cefsn
5 May 22
Windtree Therapeutics Reports First Quarter 2022 Financial Results and Provides Key Business Updates
4:04pm